<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Toxicol.</journal-id>
<journal-title>Frontiers in Toxicology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Toxicol.</abbrev-journal-title>
<issn pub-type="epub">2673-3080</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1268293</article-id>
<article-id pub-id-type="doi">10.3389/ftox.2023.1268293</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Toxicology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of TCDD exposure in adult female and male mice on the expression of miRNA in the ovaries and testes and associated reproductive functions</article-title>
<alt-title alt-title-type="left-running-head">Hall et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ftox.2023.1268293">10.3389/ftox.2023.1268293</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hall</surname>
<given-names>Alina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mattison</surname>
<given-names>Donald</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Narendra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/591772/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chatzistamou</surname>
<given-names>Ioulia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1537391/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jiajia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nagarkatti</surname>
<given-names>Mitzi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/451427/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nagarkatti</surname>
<given-names>Prakash</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/499453/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pathology</institution>, <institution>Microbiology and Immunology</institution>, <institution>School of Medicine</institution>, <institution>University of South Carolina</institution>, <addr-line>Columbia</addr-line>, <addr-line>SC</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Arnold School of Public Health</institution>, <institution>University of South Carolina</institution>, <addr-line>Columbia</addr-line>, <addr-line>SC</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1589292/overview">David R. Wallace</ext-link>, Oklahoma State University Center for Health Sciences, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1071188/overview">Hideko Sone</ext-link>, Yokohama College of Pharmacy, Japan</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1671274/overview">Isabel Alvarado-Cruz</ext-link>, University of Arizona, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/959995/overview">Anna Wajda</ext-link>, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Prakash Nagarkatti, <email>prakash@mailbox.sc.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>5</volume>
<elocation-id>1268293</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Hall, Mattison, Singh, Chatzistamou, Zhang, Nagarkatti and Nagarkatti.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hall, Mattison, Singh, Chatzistamou, Zhang, Nagarkatti and Nagarkatti</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contaminant found widely across the world. While animal and human studies have shown that exposure to TCDD may cause significant alterations in the reproductive tract, the effect of TCDD on the expression of miRNA in the reproductive organs has not been previously tested. In the current study, we exposed adult female or male mice to TCDD or vehicle and bred them to study the impact on reproduction. The data showed that while TCDD treatment of females caused no significant change in litter size, it did alter the survival of the pups. Also, TCDD exposure of either the male or female mice led to an increase in the gestational period. While TCDD did not alter the gross morphology of the ovaries and testes, it induced significant alterations in the miRNA expression. The ovaries showed the differential expression of 426 miRNAs, of which 315 miRNAs were upregulated and 111 miRNA that were downregulated after TCDD exposure when compared to the vehicle controls. In the testes, TCDD caused the differential expression of 433 miRNAs, with 247 miRNAs upregulated and 186 miRNAs downregulated. Pathway analysis showed that several of these dysregulated miRNAs targeted reproductive functions. The current study suggests that the reproductive toxicity of TCDD may result from alterations in the miRNA expression in the reproductive organs. Because miRNAs also represent one of the epigenetic pathways of gene expression, our studies suggest that the transgenerational toxicity of TCDD may also result from dysregulation in the miRNAs.</p>
</abstract>
<kwd-group>
<kwd>TCDD</kwd>
<kwd>miRNA</kwd>
<kwd>reproductive toxicity</kwd>
<kwd>ovary</kwd>
<kwd>testes</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Developmental and Reproductive Toxicology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), is an environmental pollutant that is considered to be the most persistent and strongest endocrine disruptor (<xref ref-type="bibr" rid="B32">Hites, 2011</xref>; <xref ref-type="bibr" rid="B74">Zhang et al., 2021</xref>). TCDD is also a historically controversial chemical contaminant that was produced during the high-temperature synthesis of organochloride herbicides, such as Agent Orange, which was heavily utilized during the Vietnam War (<xref ref-type="bibr" rid="B39">Kim et al., 2003</xref>; <xref ref-type="bibr" rid="B49">NASEM, 2018</xref>). Veterans exposed to TCDD contamination in Agent Orange during the war have exhibited an increased occurrence of various cancers (<xref ref-type="bibr" rid="B13">Chang et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Chang et al., 2017</xref>), dementia (<xref ref-type="bibr" rid="B46">Martinez et al., 2021</xref>), skin disorders like porphyria and chloracne (<xref ref-type="bibr" rid="B53">Patterson et al., 2016</xref>), as well as endocrine and reproductive system disease (<xref ref-type="bibr" rid="B31">Gaspari et al., 2021</xref>).</p>
<p>TCDD toxicity is mediated through the aryl hydrocarbon receptor (AhR) which is translocated to the nucleus after ligand binding. Here, it forms a heterodimer with the aryl hydrocarbon receptor nuclear translocator (ARNT) protein which can then directly interact with genes containing Dioxin Response Elements (DREs) (<xref ref-type="bibr" rid="B24">Enan and Matsumara, 1996</xref>; <xref ref-type="bibr" rid="B57">Rothhammer and Quintana, 2019</xref>). These DREs alter gene expression resulting in changes in physiopathology including both immunosuppressive and inflammatory processes (<xref ref-type="bibr" rid="B16">Clark et al., 1981</xref>; <xref ref-type="bibr" rid="B22">Dominques-Acosta et al., 2018</xref>; <xref ref-type="bibr" rid="B66">Vasquez-Gomez et al., 2022</xref>). TCDD exposure has been observed to disrupt normal immune system development and functions such as increasing thymic atrophy (<xref ref-type="bibr" rid="B17">De Heer et al., 1994</xref>; <xref ref-type="bibr" rid="B30">Frazier et al., 1994</xref>; <xref ref-type="bibr" rid="B38">Kamath et al., 1997</xref>; <xref ref-type="bibr" rid="B11">Camacho et al., 2005</xref>), alterations to thymocyte development (<xref ref-type="bibr" rid="B28">Fine et al., 1990</xref>) and increased T-cell apoptosis (<xref ref-type="bibr" rid="B60">Singh et al., 2020</xref>). Additionally, hormone synthesis and circulation disruption has also been observed, following TCDD exposure, in the thyroid (<xref ref-type="bibr" rid="B41">Kohn, 2000</xref>), hypothalamus (<xref ref-type="bibr" rid="B27">Fetissov et al., 2004</xref>), pituitary and adrenal glands (<xref ref-type="bibr" rid="B7">Bestervelt et al., 1993</xref>).</p>
<p>In addition to modulating gene expression and hormone activity, direct effects on reproductive success have been observed after exposure to dioxin in murine models. Previous research from our laboratory has revealed TCDD induces a loss of mitochondrial membrane potential in epididymal spermatozoa, potentially reducing sperm quality and motility (<xref ref-type="bibr" rid="B29">Fisher et al., 2005</xref>) as well as reducing testes&#x27; weight and circulating testosterone levels (<xref ref-type="bibr" rid="B15">Choi et al., 2008</xref>; <xref ref-type="bibr" rid="B74">Zhang et al., 2021</xref>). Paternal exposure to TCDD has been shown to distort the sex ratio of the offspring, increasing the proportion of females per litter (<xref ref-type="bibr" rid="B8">Bircsak et al., 2020</xref>). Females exposed to TCDD had increased rates of endometriosis and ovarian cancers (<xref ref-type="bibr" rid="B35">Johnson et al., 1997</xref>; <xref ref-type="bibr" rid="B10">Bruner-Tran et al., 2017</xref>) as well as altered ovarian function (<xref ref-type="bibr" rid="B63">Tischkau et al., 2011</xref>), and reduced estradiol synthesis (<xref ref-type="bibr" rid="B65">Valdez et al., 2009</xref>). Epigenetic changes induced by TCDD are heritable and directly observable at the germ line (<xref ref-type="bibr" rid="B52">Patrizi and Siciliani de Cumis, 2018</xref>). By studying these alterations at the gonad level, one can better characterize the long-term and transgenerational risk of exposure.</p>
<p>Increased expression of genes containing DREs is not the only transcriptional disruption induced by TCDD. TCDD can also alter the expression of mRNA through dysregulation of miRNA (<xref ref-type="bibr" rid="B62">Singh et al., 2012</xref>; <xref ref-type="bibr" rid="B2">AlGhezi et al., 2019</xref>; <xref ref-type="bibr" rid="B50">Neamah et al., 2019</xref>) which are short, &#x223c;20&#xa0;bp long, non-coding RNAs that regulate gene translation by silencing target mRNA sequences (<xref ref-type="bibr" rid="B51">O&#x2019;Brien et al., 2018</xref>). However, some miRNA express DREs in their 3&#x2032; UTR, thereby enabling TCDD to directly alter their expression through DRE-dependent pathways (<xref ref-type="bibr" rid="B21">Disner et al., 2021</xref>). miRNAs serve as critical epigenetic modulators, altering the protein levels of the target mRNAs without changing the gene sequences (<xref ref-type="bibr" rid="B71">Yao et al., 2019</xref>).</p>
<p>The effect of <italic>in vivo</italic> exposure to TCDD on miRNA expression in the reproductive organs and its impact on reproductive functions has not been previously studied. However, there are a few reports on the <italic>in vitro</italic> effects of TCDD on miRNA expression in cells such as Chinese Hamster Ovary (CHO) cells (<xref ref-type="bibr" rid="B58">Sadowska, et al., 2021</xref>) and human Sertoli cells (<xref ref-type="bibr" rid="B55">Ribeiro, et al., 2018</xref>), the former study showing no significant changes in miRNA expression while the latter showing significant alterations. The present study investigated the miRNA expression in the ovaries and testes of adult mice exposed to TCDD and the genes targeted by those miRNAs. Our data demonstrate that TCDD alters the expression of a large number of miRNAs and several of them target the gene expression involved in the regulation of reproductive functions.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Mice</title>
<p>Male and Female C57BL/6J mice aged 5&#x2013;6&#xa0;weeks were purchased from Jackson Laboratories (Bar Harbor, ME, United States 04609) and housed at the AAALAC-accredited DLAR animal facility at the University of South Carolina School of Medicine (Columbia, SC, United States 20208) under specific pathogen-free conditions. Before and throughout the experiment, animals were maintained in temperature and humidity-controlled rooms on 12-h light/dark cycles and provided with access to food and normal rodent chow <italic>ad libitum.</italic> Female mice were housed together in cages of five without male contact before random pairing and/or treatment to allow for estrus cycles to synchronize. All experiments were performed in accordance with ethical standards approved by the University of South Carolina Institutional Animal Care and Use Committee.</p>
</sec>
<sec id="s2-2">
<title>TCDD exposure and mating pairs</title>
<p>TCDD was generously provided by Dr. Steve Safe (Institute of Biosciences &#x26; Technology, Texas A&#x26;M Health Science Center, College Station, TX, United States) and was dissolved in DMSO to a working stock concentration of 100&#xa0;&#x3bc;g/mL. The stock was combined with medical-grade corn oil for a total volume of 100&#xa0;&#xb5;L injected intraperitoneally (I.P). Mice were dosed at 10&#xa0;&#x3bc;g/kg body weight similar to other studies which have used similar doses (<xref ref-type="bibr" rid="B6">Besteman, et al., 2007</xref>; <xref ref-type="bibr" rid="B43">Li, et al., 2022</xref>). Male and female mice were either treated with TCDD or vehicle, the latter consisting of an equal amount of DMSO in corn oil, then immediately paired with one male to one female per cage for initial reproductive success assessment. Treatment and pairing design are described in <xref ref-type="fig" rid="F1">Figure 1A</xref>. For miRNA expression analysis, male and female mice were treated as previously described, kept with their original same-sex cage mates, and sacrificed 72-h post-exposure.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Effect of TCDD exposure on reproductive functions. There were four groups of mice: 1) Adult female mice treated with TCDD and mated with male mice treated with vehicle, 2) Adult female mice treated with vehicle and mated with male mice treated with TCDD, 3) Both male and female mice treated with TCDD, 4) Both male and female mice treated with vehicle. Such mice were then paired and following pregnancy, the pregnant mice were observed for the number of pups delivered, the percentage of pup survival per litter for up to 4&#xa0;weeks, and the number of days taken from the sighting of vaginal plug to the birth of the pups. Reproductive success parameters by treatment group were measured as follows: <bold>(B)</bold> litter size at the time of birth, <bold>(C)</bold> post-natal pup survivorship to weaning age, <bold>(D)</bold> time from pairing to birth. Significance was determined using Student&#x2019;s t-test with <italic>n</italic> &#x3d; 10. The asterisk denotes as follows: &#x2a; &#x3c;0.05, &#x2a;&#x2a;&#x3c;0.01.</p>
</caption>
<graphic xlink:href="ftox-05-1268293-g001.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>Reproductive parameter assessment</title>
<p>After treatment and pairing, the female mice were examined for the vaginal plug, the sighting of which was considered as possible day 1 of pregnancy. Next, the mated pairs were left undisturbed until females were visibly pregnant at which time males were removed for parturition. Daily monitoring of females was conducted and measurements such as days since pairing, number of pups born in a litter, and number of neonates found deceased in the cage were recorded until weaning age was reached at 4&#xa0;weeks.</p>
</sec>
<sec id="s2-4">
<title>Histology</title>
<p>Mice were euthanized with an overdose of inhaled isoflurane and testes and ovaries were excised from the male and female mice, respectively, rinsed with PBS, and immersed in 4% paraformaldehyde (PFA). Paraffin embedding, cutting, and mounting, and H&#x26;E staining was performed on-site through the University of South Carolina School of Medicine Instrument Resource Facility (IRF). Imaging was conducted on a Keyence BZ-X800 Automated High-resolution Fluorescence Microscope (Keyence Corporation of America, Itasca, IL, United States 60143).</p>
</sec>
<sec id="s2-5">
<title>Tissue processing and miRNA isolation</title>
<p>Testes and ovaries were excised and placed in blender bags containing RPMI medium containing FBS (10% v/v) and an antibiotic cocktail including penicillin and streptomycin. All tissues were kept on ice during processing. Tissues were homogenized using a Seward &#x2122; Stomacher &#x2122; Model 80 Biomaster Blender 110&#xa0;V (Seward Inc, Bohemia, NY, United States) and filtered using 100&#xa0;&#xb5;m mesh filters. The resulting filtrate was centrifuged at 350 &#xd7; g for 7&#xa0;min and the supernatant was discarded. The remaining cell pellet was resuspended in 700&#xa0;&#xb5;L of QIAzol &#x2122; Lysis reagent (QIAGEN, Germantown, MD, United States 20874). miRNA was isolated using a QIAGEN miRNEasy Micro Kit (QIAGEN, Germantown, MD, United States 20874) according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2-6">
<title>miRNA microarray</title>
<p>miRNA arrays were performed as described previously (<xref ref-type="bibr" rid="B2">Al-Ghezi et al., 2019</xref>). Purified miRNA samples isolated from testes and ovaries harvested from mice 72&#xa0;h post-exposure to TCDD were labeled using the Affymetrix<sup>&#xae;</sup> FlashTag&#x2122; Biotin HSR RNA Labeling Kit using the manufacturer&#x2019;s specifications for 100 format miRNA 4.0 arrays. GeneChip&#x2122; Hybridization, Wash, and Stain kit was used in conjunction with the Affymetrix<sup>&#xae;</sup> Hybridization Oven and Affymetrix<sup>&#xae;</sup> Fluidics Station on the 450 protocol to prepare Affymetrix<sup>&#xae;</sup> GeneChip<sup>&#xae;</sup> miRNA 4.0 arrays. Prepared arrays were then analyzed using the GeneChip&#x2122; Scanner 3,000 7G (All products in this section are sourced from ThermoFisher Scientific, Waltham, MA, United States 02451). Microarray intensity was quantified, and differential expression was analyzed using Applied Biosystems Transcription Analysis Console (TAC) 4.0 software. Expression data were analyzed using Ingenuity Pathway Analysis (IPA) and miRNA targets were determined using the current target prediction database miRDB (<xref ref-type="bibr" rid="B75">Chen and Wang, 2020</xref>), and target prediction algorithm, MirTarget as well as web-based TargetScan. MicroRNA raw data have been deposited to Geo database (accession number is GSE241576 and can be accessed by <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/info/linking.html">https://www.ncbi.nlm.nih.gov/geo/info/linking.html</ext-link>) of National Institute of Health (NIH).</p>
</sec>
<sec id="s2-7">
<title>Real-time quantitative PCR (RT-qPCR) to validate the expression of miRNAs and genes</title>
<p>miRNAs and target mRNAs of interest were validated using Real-Time PCR. To synthesize cDNA, iScript&#x2122; cDNA Synthesis Kit from Bio-RAD (BIO-RAD, Herculeus, VCA) was used. RT-qPCR using SYBR<sup>&#xae;</sup> Green qPCR Supermix from Qiagen (Qiagen, Valencia, CA) was used following the protocol of the company. Real-qPCR was performed on a BIO-RAD CFX Connect RT-PCR Detection System (BIO-RAD, Hercules, CA). RT-qPCR was performed for 40 cycles and using the following conditions: initial activation step (5&#xa0;min at 95&#xb0;C), denaturing temperature (15&#xa0;s at 94&#xb0;C), annealing temperature (30&#xa0;s at 55&#xb0;C), and extension temperature and fluorescence data collection (30&#xa0;s at 70&#xb0;C). Normalized expression (NE) of miRs and genes were calculated using NE &#xbc; 2_DDCt, where Ct is the threshold cycle to detect fluorescence. The expression of miRNAs was normalized against internal control for miRNA and fold change of miRNAs expression was calculated against the internal control SNORD96A, and the treatment group (TCDD) was compared with the vehicle group. Similarly, the value of genes was normalized against the housekeeping gene (18&#xa0;S) and fold-change of genes was calculated against 18&#xa0;S and the TCDD group was compared with the vehicle group. To define significant differences in the expression of miRNAs and genes, ANOVA was performed using GraphPad version 6.0 (GraphPad Software, Inc., San Diego, CA, United States), and differences between the groups were considered significant when <italic>p</italic> &#x3c; 0.05.</p>
</sec>
<sec id="s2-8">
<title>Data analysis and statistics</title>
<p>We used groups of 10 mice injected with TCDD or the vehicle which were then allowed to mate for studies on reproduction. In other studies, we used groups of 5 mice for studies on the ovaries and testes. For miRNA microarray analysis, we pooled the ovaries or testes from 5 animals while the validation of miRNA using RT-qPCR was performed on individual mice with <italic>n</italic> &#x3d; 5. The statistical significance was determined using a one-way ANOVA followed by Tukey&#x2019;s <italic>post hoc</italic> test.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Reproductive success is modulated by parental exposure to TCDD</title>
<p>Wild type C57BL/6J male and female mice were exposed to Vehicle or TCDD as described in Methods, paired, and allowed to mate as described in <xref ref-type="fig" rid="F1">Figure 1A</xref>. There were 4 groups of mice: 1) Female mice exposed to TCDD mated with male mice treated with Vehicle (Maternal). 2) Male mice exposed to TCDD mated with female mice treated with Vehicle (Paternal). 3) Both male and female mice exposed to TCDD (Dual). 4) Both male and female mice exposed to Vehicle only (Vehicle).</p>
<p>The pregnant mice were observed for the number of pups delivered, the percentage of pup survival per litter up to 4&#xa0;weeks of observation, and the number of days taken from pairing to the birth of the pups. The maternal, paternal, or dual exposure to TCDD did not significantly alter the litter size (&#x23; of pups/litter) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). However, the survival of the pups was significantly impacted by TCDD exposure. Specifically, maternal but not paternal exposure to TCDD caused a significant decrease in the survival of pups to weaning age when compared to the Vehicle group (<xref ref-type="fig" rid="F1">Figure 1C</xref>). The non-surviving pups were born alive, but it was unclear if subsequent post-natal mortality was due to health complications or live cannibalism by the mother. Additionally, the gestation period was significantly delayed following maternal exposure to TCDD but not after paternal exposure when compared to the Vehicle controls (<xref ref-type="fig" rid="F1">Figure 1D</xref>). Together, these data suggested that maternal but not paternal exposure to TCDD significantly alters the pregnancy and the survival of the pups.</p>
</sec>
<sec id="s3-2">
<title>TCDD induces changes in miRNA expression in the ovaries</title>
<p>Gross and histologic examination of the ovaries of TCDD-treated mice showed no significant differences, and several ovarian follicles at various stages of development were observed in the cortex, that were similar in the TCDD and the Vehicle controls (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Next, we investigated if maternal exposure to TCDD would alter the expression of miRNA in the ovaries by using iGeneChip miRNA microarray. These studies revealed the differential expression of 426 miRNAs in the ovaries, of which 315 miRNAs were upregulated and 111 miRNAs were downregulated after TCDD exposure by &#x2265; 2-fold when compared to the Vehicle control (<xref ref-type="fig" rid="F2">Figure 2B</xref>). The heatmap of some of the most dysregulated miRNAs has been depicted in <xref ref-type="fig" rid="F2">Figure 2C</xref>, which shows marked differences between the two groups.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effect of TCDD on histopathology and miRNA expression in the ovaries. Adult female mice were treated with TCDD or the Vehicle and 3&#xa0;days later, the ovaries were harvested for analysis as described in Methods. <bold>(A)</bold> Mouse ovaries sections stained with H&#x26;E at &#xd7;10 magnification were collected from females 72&#xa0;h after treatment with either Vehicle or TCDD. <bold>(B)</bold> GeneChip miRNA 4.0 microarray differential expression analysis of miRNA isolated from mouse ovaries. miRNAs with relative expression &#x2265;2 were considered for downstream analysis. <bold>(C)</bold> Expression heat map of miRNA that were highly dysregulated in the mouse ovaries.</p>
</caption>
<graphic xlink:href="ftox-05-1268293-g002.tif"/>
</fig>
<p>Ingenuity Pathway Analysis of some select highly dysregulated miRNA revealed how these miRNAs were predicted to target various upstream regulators and downstream mRNA targets involved with reproductive disease and normal fetal development (<xref ref-type="fig" rid="F3">Figure 3A</xref>). The predicted miRNA/mRNA interactions were also confirmed through alignment using TargetScan (<xref ref-type="fig" rid="F3">Figure 3B</xref>). For example, miR-34c was downregulated in the TCDD-treated group which targeted Tumor protein 53 apoptosis inducing protein 1 (TP53AIP1) and Tumor protein 53 inducible protein 11 (TP53I11), key regulatory molecules involved in the maintenance of homeostasis when the cells are in a state of stress and shown to be involved in preeclampsia (<xref ref-type="bibr" rid="B4">Ali et al., 2021</xref>).TCDD also decreased the levels of miR-192 which targeted epiregulin (EREG) known to stimulate oocytes (<xref ref-type="bibr" rid="B56">Romero and Smitz, 2009</xref>). TCDD upregulated miR-362 and miR-194 which targeted Alx Homebox Protein 1 (ALX1) and Ras family protein 2&#xa0;B (RAP2B), respectively. Loss of ALX1 function is associated with birth defects (<xref ref-type="bibr" rid="B34">Iyyanar et al., 2022</xref>) while RAP2B is involved in cell proliferation and migration (<xref ref-type="bibr" rid="B20">Di et al., 2015</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Characterization of TCDD-mediated alterations in miRNA expression in the ovaries and their predicted targets. <bold>(A)</bold> Ingenuity Pathway Analysis network of specific dysregulated miRNAs, downstream targets, and upstream regulators. <bold>(B)</bold> Predicted alignments of miRNA and downstream mRNA target sequences sourced from TargetScan. <bold>(C)</bold> RT-qPCR relative quantification of miRNAs of interest and potential mRNA targets in the ovaries. In Panel C, <italic>n</italic> &#x3d; 5 and the Asterix denotes as follows: &#x2a; &#x3c;0.05, &#x2a;&#x2a;&#x3c;0.01, &#x2a;&#x2a;&#x2a;&#x3c;0.001, &#x2a;&#x2a;&#x2a;&#x2a;&#x3c;0.0001.</p>
</caption>
<graphic xlink:href="ftox-05-1268293-g003.tif"/>
</fig>
<p>To validate the miRNA array data and to confirm the effect of altered miRNA expression on the target genes, we performed RT-qPCR of miRNAs of interest and their potential targets (<xref ref-type="fig" rid="F3">Figure 3C</xref>). The data showed that TCDD-exposed ovaries had decreased levels of miR-34c which correlated with increased expression of TP53AIPI and TP53I11 (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Additionally, TCDDD exposure led to increased expression of miR-362 and miR-194 which correlated with decreased expression of ALX1 and RAP2B (<xref ref-type="fig" rid="F3">Figure 3C</xref>).</p>
</sec>
<sec id="s3-3">
<title>TCDD induces changes in miRNA expression in the testes</title>
<p>Next, we investigated the effect of TCDD exposure on miRNA expression in the testes. No significant differences in gross morphology of the testes from male mice treated with TCDD were observed when compared to the Vehicle controls, and histologically, the TCDD-treated groups showed normal spermatogenesis (<xref ref-type="fig" rid="F4">Figure 4A</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of TCDD on histopathology and miRNA expression in the testes. Adult male mice were treated with TCDD or the Vehicle and 3 days later, the testes were harvested for analysis as described in Methods. <bold>(A)</bold> Mouse testes sections stained with H&#x26;E at &#xd7;10 magnification were collected from females 72&#xa0;h after treatment with either Vehicle or TCDD. <bold>(B)</bold> GeneChip miRNA 4.0 microarray differential expression analysis of miRNA isolated from mouse testes. miRNAs with relative expression &#x2265;2 were considered for analysis. <bold>(C)</bold> Expression heat map miRNA isolated from mouse testes that were highly dysregulated.</p>
</caption>
<graphic xlink:href="ftox-05-1268293-g004.tif"/>
</fig>
<p>Next, we investigated the effect of TCDD exposure on miRNA expression in the testes. Between males treated with Vehicle or TCDD, no significant differences in gross morphology were observed and normal spermatogenesis was noted in both (<xref ref-type="fig" rid="F4">Figure 4A</xref>). GeneChip miRNA microarray of the testes revealed differential expression of 433 miRNAs, with 247 miRNAs upregulated and 186 miRNAs downregulated after exposure to TCDD (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Some of the highly dysregulated miRNAs following TCDD treatment have been depicted in the form of a heatmap in <xref ref-type="fig" rid="F4">Figure 4C</xref>.</p>
<p>Ingenuity Pathway Analysis of some of the highly dysregulated miRNA showed targeting of genes involved in cell signaling pathways (<xref ref-type="fig" rid="F5">Figure 5A</xref>). These dysregulated functional clusters revealed significant upregulation of certain miRs such as miR-448 and miR-let-7a as well as significant downregulation of miR-219a, and miR-15 and predicted various upstream regulators and downstream mRNA targets (<xref ref-type="fig" rid="F5">Figure 5A</xref>). The predicted miRNA/mRNA interactions were aligned using TargetScan (<xref ref-type="fig" rid="F5">Figure 5B</xref>). RT-qPCR of miRNAs of interest and potential mRNA targets revealed that upregulation of miRNA such as miR-448 and miR-let-7a was associated with decreased expression of specific targets such as DEAD-Box Helicase 20 (DDX20) and Sperm acrosome associated protein 6 (SPACA6), respectively. Moreover, decreased expression of miR-219a, and miR-15 was associated with increased expression of binding motif single-stranded interacting protein 1 (RBMS1), Bcl-like protein L2 (BCL2L2), and Argonaut RISC catalytic component 2 (AGO2).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Characterization of TCDD-mediated alterations in miRNA expression and their predicted targets in the testes. <bold>(A)</bold> Ingenuity Pathway Analysis network of specific dysregulated miRNAs, downstream targets, and upstream regulators. <bold>(B)</bold> Predicted alignments of specific miRNA and downstream mRNA target sequences sourced from TargetScan. <bold>(C)</bold> RT-qPCR relative quantification of miRNAs of interest and potential mRNA targets in the testes. In Panel C, <italic>n</italic> &#x3d; 5 and the Asterix denotes as follows: &#x2a; &#x3c;0.05, &#x2a;&#x2a;&#x3c;0.01, &#x2a;&#x2a;&#x2a;&#x3c;0.001, &#x2a;&#x2a;&#x2a;&#x2a;&#x3c;0.0001.</p>
</caption>
<graphic xlink:href="ftox-05-1268293-g005.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Comparison of miRNA alterations between testes and ovaries and pathway analysis of miRNA to predict a targeted effect on various disorders</title>
<p>When we compared the miRNA expression changes between the testes and the ovaries, we noted that the TCDD-exposed testes had 247 miRNA upregulated while the ovaries had 315 miRNA that were upregulated (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Also, of these upregulated miRNA, 7.66% shared similar upregulation among these two organs (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Also, the testes showed 186 miRNA to be downregulated following TCDD exposure while the ovaries showed 111 miRNA to be downregulated (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Additionally, these two organs showed 9.19% of such miRNA to be similarly downregulated (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Interestingly, only a small number (1.7%) of the dysregulated miRNA showed reciprocal alterations such as upregulation in the testes and downregulation in the ovaries (<xref ref-type="fig" rid="F6">Figure 6C</xref>). Also, 8.91% of the dysregulated miRNA showed reciprocal alterations such as downregulation in the testes and upregulation in the ovaries (<xref ref-type="fig" rid="F6">Figure 6D</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Analysis of miRNA showing similar or dissimilar alterations in the ovaries and testes. Venn diagram showing miRNA that are upregulated <bold>(A)</bold> or downregulated <bold>(B)</bold> in ovaries and testes. The data show the numbers of miRNA changes that are unique to each organ as well as shared by the two organs. Panel C shows sharing of miRNA that were upregulated in testes and downregulated in ovaries, and <italic>vice versa</italic> <bold>(D)</bold>.</p>
</caption>
<graphic xlink:href="ftox-05-1268293-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>TCDD or dioxin is a highly prevalent environmental contaminant. It is created by natural events such as volcanic eruptions and forest fires, and waste incineration, paper bleaching using chlorine, and certain plastics manufacture (<xref ref-type="bibr" rid="B73">Zhang et al., 2015</xref>). It was also found as a contaminant in Agent Orange, an herbicide used extensively during the Vietnam War which led to significant exposure of the Vietnam War Veterans as well as Vietnam civilians (<xref ref-type="bibr" rid="B59">Scialli et al., 2015</xref>). A chemical factory explosion near Seveso, Italy exposed the residents to high levels of TCDD (<xref ref-type="bibr" rid="B26">Eskenazi et al., 2018</xref>). TCDD is considered to be a human carcinogen and a potent endocrine disruptor (<xref ref-type="bibr" rid="B10">Bruner-Tran et al., 2017</xref>). Because it is highly lipophilic, following exposure, it can stay for a very long period in the body thereby causing chronic toxicity (<xref ref-type="bibr" rid="B33">Huff et al., 1991</xref>). The half-life of TCDD in humans is estimated to be around 7&#x2013;9&#xa0;years (<xref ref-type="bibr" rid="B54">Pirkle et al., 1989</xref>). Reports on human exposures and experimental studies have revealed that TCDD exposure is associated with chloracne of the skin, organ cancers, hepatotoxicity, gonadal and immune changes, pulmonary and other diseases such as diabetes, skewing of the sex ratio, and infertility (<xref ref-type="bibr" rid="B40">Kociba and Schwetz, 1982</xref>; <xref ref-type="bibr" rid="B9">Birnbaum, 1994</xref>; <xref ref-type="bibr" rid="B37">Kamath et al., 1998</xref>; <xref ref-type="bibr" rid="B36">Kamath et al., 1999</xref>; <xref ref-type="bibr" rid="B61">Singh et al., 2007</xref>).</p>
<p>The ability of TCDD to act as an endocrine disruptor suggests that it can have a significant impact on reproductive health. In fact, animal studies have revealed that exposure to TCDD in adult female mice can lead to transgenerational disorders involving reproductive functions that have been linked to endometriosis and other defects in women (<xref ref-type="bibr" rid="B10">Bruner-Tran et al., 2017</xref>). In certain species, exposure to TCDD is known to cause decreased fecundity and reduced ovulatory rate. Similarly, in humans, TCDD exposure was associated with decreased fertility in Seveso mothers and their daughters exposed <italic>in utero</italic> (<xref ref-type="bibr" rid="B25">Eskenazi et al., 2021</xref>).</p>
<p>The current study revealed that exposure of adult female mice to TCDD was significantly linked to poor survivorship of neonates but had no effect on the litter size at birth. Also, TCDD exposure led to an increase in the gestational period. The decreased survival of the pups was seen only when adult female but not adult male mice were exposed to TCDD. However, the increase in the gestational period was seen when either both male or female mice were exposed to TCDD. This suggests that maternal TCDD exposure may interfere with normal pup development or induces postpartum stress which can trigger cannibalism. The precise cause of postnatal mortality in the mouse is unclear and it is suggested that causes other than infanticide play a critical role (<xref ref-type="bibr" rid="B69">Weber et al., 2013</xref>).</p>
<p>miRNAs constitute noncoding RNAs that have been shown to play a critical role in the posttranscriptional regulation of gene expression. In the reproductive system, the miRNAs can regulate oocyte maturation, folliculogenesis, corpus luteum function, implantation, and early embryonic development (<xref ref-type="bibr" rid="B23">Eisenberg et al., 2015</xref>). It has been shown that deletion of Dicer, the enzyme that cleaves the pre-miRNA to the mature form, leads to post-implantation embryonic lethality in many animal models, thereby suggesting that miRNA plays a critical role in reproduction and development (<xref ref-type="bibr" rid="B47">Meng et al., 2013</xref>).</p>
<p>miRNA is expressed in the ovaries and is known to regulate the formation of primordial follicles, oocyte-cumulus cell interactions, granulosal cell function, and luteinization (<xref ref-type="bibr" rid="B45">Maalouf et al., 2016</xref>). In the current study, TCDD exposure in female mice upregulated the expression of mmu-miR-362 in the ovaries and decreased the expression of its target, ALX1, a homeobox protein-coding gene necessary for the normal development of the head and face, especially the eyes, nose, and mouth (<xref ref-type="bibr" rid="B34">Iyyanar et al., 2022</xref>). Poor development of these critical features may compromise neonate health, thereby prompting the mothers to cannibalize the litter. Additionally, downregulation of miR-34c suppressed the normal post-transcriptional silencing of two genes TP53I11 and TP53AIPI, which play an important role in mediating p53-dependent apoptosis. P53 is a tumor protein that acts as a tumor suppressor and is negatively regulated by proteins encoded by both TP53I11 and TP53AIPI. Both genes were upregulated in the ovaries, possibly as a response to the teratogenic and oncogenic nature of TCDD. TP53I11 and TP53AIPI have also been shown to regulate homeostasis when the cells are in a state of stress and shown to be involved in preeclampsia (<xref ref-type="bibr" rid="B4">Ali et al., 2021</xref>). Additionally, miR-192 was upregulated in TCDD-exposed ovaries while downstream target EREG was significantly downregulated. EREG is involved with various biological processes but may also be associated with promoting cancers in various tissues (<xref ref-type="bibr" rid="B45">Maalouf et al., 2016</xref>). In the reproductive system, EREG is known to stimulate oocytes (<xref ref-type="bibr" rid="B56">Romero and Smitz, 2009</xref>). Likewise, miR-194 was significantly upregulated in TCDD-treated females while downstream target RAP2B was suppressed. RAP2B is a protein-encoding gene in the RAS oncogene family and is involved with the proliferation and migration of various cancer types (<xref ref-type="bibr" rid="B18">Di et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Di et al., 2017</xref>; <xref ref-type="bibr" rid="B72">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="B44">Li et al., 2018</xref>; <xref ref-type="bibr" rid="B48">Miao et al., 2019</xref>).</p>
<p>Recent studies have shown that miRNAs play a critical role in spermatogenesis, especially during mitotic, meiotic, and post-meiotic stages of spermatogenesis (<xref ref-type="bibr" rid="B68">Wang and Xu, 2015</xref>). In the current study, we found that while exposure of male mice to TCDD did not alter the litter size or the survival of the pups, there was an increase in the time from pairing to parturition. Upregulation of two select miRNAs; miR-448 and mir-let-7a and the silencing of their downstream targets, DDX20 and SPACA6, respectively, may be involved in altering the testicular functions. DDX20 is a DEAD box protein-encoding gene that is involved in several cellular activities and based on distribution patterns, may be involved in spermatogenesis and embryogenesis (<xref ref-type="bibr" rid="B42">Lee et al., 2005</xref>). SPACA6 is a sperm acrosome membrane-associated protein directly involved in the fusion of sperm to egg plasma membrane (<xref ref-type="bibr" rid="B5">Barbaux et al., 2020</xref>).</p>
<p>Additionally, downregulation of two miRNAs; miR-219a and miR-15 in the testes by TCDD correlated with significant upregulation in their respective downstream targets RBMS1, and BCL2L2, as well as AGOT2 involved with cellular proliferation and apoptosis. BCL2L2 has additionally been shown to be critical in adult spermatogenesis and dysregulation of BCL-2 family proteins can induce germ cell apoptosis (<xref ref-type="bibr" rid="B67">Vergara et al., 2011</xref>). Lastly, while miR-15 targeted AGO2, it was suggested to act as an upstream regulator of miR-15, and AGO2 was also dysregulated in the ovaries treated with TCDD. This suggested an inverse relationship between AGOT and miR-15. Also, the pathway analysis of all dysregulated miRNA in the ovaries and testes revealed that these miRNA alterations affected to a greater extent, reproductive system diseases, organismal injury and abnormalities, and cancer, consistent with previous studies showing TCDD-mediated systemic toxicities.</p>
<p>AhR activation by TCDD leads to two distinct pathways of the regulation of gene expression: the canonical pathway and the non-canonical pathway (<xref ref-type="bibr" rid="B70">Wright, et al., 2017</xref>). In the canonical pathway, the AhR upon ligation, dimerizes with the AhR nuclear translocator (ARNT) and subsequently interacts with DREs leading to the induction of the genes that express DREs. In the non-canonical pathway, the AhR forms a complex with other molecules allowing it to bind to genes lacking DRE sequences leading to either induction or repression of gene expression (<xref ref-type="bibr" rid="B64">Viluksela and Pohjanvirta, 2019</xref>; <xref ref-type="bibr" rid="B3">Alhamad, et al., 2022</xref>). While the precise mechanisms through which TCDD regulates miRNA in this study is unclear, we and others have shown previously that some miRNAs express dioxin response elements (DRE) in their 3&#x2019; UTR and the induction of such miRNAs occurs through DRE-dependent pathway (<xref ref-type="bibr" rid="B50">Neamah, et al., 2019</xref>; <xref ref-type="bibr" rid="B60">Singh, et al., 2020</xref>). In the current study, we investigated the miRNAs for the expression of DREs using <italic>in silico</italic> analysis and found interestingly that all the miRNA that were altered by TCDD (<xref ref-type="fig" rid="F3">Figures 3</xref>, <xref ref-type="fig" rid="F5">5</xref>) such as miR-362, -34c, -192 -194, -448, -let-7a, and -15, expressed DREs. Thus, TCDD may use canonical pathway to regulate miRNA expression in the reproductive organs, although the use of non-canonical pathways cannot be ruled out.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>The current study demonstrates for the first time that exposure of adult male and female mice to TCDD results in significant alterations in a large number of miRNAs in the ovaries and the testes. These findings suggest that environmental contaminants such as TCDD may alter reproductive functions through alterations in the expression of miRNAs. Future studies will focus on whether such miRNA changes also occur in the germ cells which would explain how TCDD exerts transgenerational effects on the reproductive system by regulating epigenetic pathways involving miRNA.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>MicroRNA raw data have been deposited to Geo database (accession number is GSE241576 and can be accessed by <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/info/linking.html">https://www.ncbi.nlm.nih.gov/geo/info/linking.html</ext-link>) of National Institute of Health (NIH).</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by the University of South Carolina Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>AH: Data curation, Formal Analysis, Project administration, Software, Writing&#x2013;original draft. DM: Formal Analysis, Methodology, Supervision, Writing&#x2013;review and editing. NS: Formal Analysis, Data curation, Validation, Visualization, Writing&#x2013;review and editing. IC: Methodology, Validation, Visualization, Writing&#x2013;review and editing. JZ: participated in curation and analysis of data and reviewing the manuscript. MN: Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Software, Supervision, Visualization, Writing&#x2013;review and editing. PN: Conceptualization, Formal Analysis, Funding acquisition, Project administration, Resources, Software, Supervision, Visualization, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study was supported in part by NIH R01ES030144, R01AI123947, R01AI160896, R01AI129788, P20GM103641 and P01AT003961 to PN and MN.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Ghezi</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mehrpouya-Bahrami</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Busbee</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>AhR activation by TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) attenuates pertussis toxin-induced inflammatory responses by differential regulation of tregs and Th17 cells through specific targeting by microRNA</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>, <fpage>2349</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.02349</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alhamad</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Bensreti</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>HamrickMcGee-Lawrence</surname>
<given-names>M. W. M. E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Aryl hydrocarbon receptor (AhR)-mediated signaling as a critical regulator of skeletal cell biology</article-title>. <source>J. Mol. Endocrinol.</source> <volume>69</volume>, <fpage>R109</fpage>&#x2013;<lpage>R124</lpage>. <pub-id pub-id-type="doi">10.1530/JME-22-0076</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zafar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Zaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khaliq</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lone</surname>
<given-names>K. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Expression levels of MiRNA-16, SURVIVIN and TP53 in preeclamptic and normotensive women</article-title>. <source>J. Pak Med. Assoc.</source> <volume>71</volume> (<issue>9</issue>), <fpage>2208</fpage>&#x2013;<lpage>2213</lpage>. <pub-id pub-id-type="doi">10.47391/JPMA.1171</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbaux</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ialy-Radio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chalbi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dybal</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Homps-Legrand</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Do Cruzeiro</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Sperm SPACA6 protein is required for mammalian Sperm-Egg Adhesion/Fusion</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>5335</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-62091-y</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Besteman</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Huckle</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Prater</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Gogal</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Holladay</surname>
<given-names>S. D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or diethylstilbestrol (DES) cause similar hematopoietic hypocellularity and hepatocellular changes in murine fetal liver, but differentially affect gene expression</article-title>. <source>Toxicol. Pathol.</source> <volume>35</volume> (<issue>6</issue>), <fpage>788</fpage>&#x2013;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1080/01926230701584155</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bestervelt</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Pitt</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Nolan</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Piper</surname>
<given-names>W. N.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>TCDD alters pituitary-adrenal function. II: evidence for decreased bioactivity of ACTH</article-title>. <source>Neurotoxicol Teratol.</source> <volume>15</volume> (<issue>6</issue>), <fpage>371</fpage>&#x2013;<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1016/0892-0362(93)90053-q</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bircsak</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Copes</surname>
<given-names>L. T.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Prantner</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Gerton</surname>
<given-names>G. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The aryl hydrocarbon receptor mediates sex ratio distortion in the embryos sired by TCDD-exposed male mice</article-title>. <source>Reprod. Toxicol.</source> <volume>94</volume>, <fpage>75</fpage>&#x2013;<lpage>83</lpage>. <comment>Epub 2020 Apr 23</comment>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2020.04.072</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birnbaum</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>The mechanism of dioxin toxicity: relationship to risk assessment</article-title>. <source>Environ. Health Perspect.</source> <volume>102</volume>, <fpage>157</fpage>&#x2013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.94102s9157</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruner-Tran</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Gnecco</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Glore</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Pensabene</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Osteen</surname>
<given-names>K. G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: translating lessons from murine models</article-title>. <source>Reprod. Toxicol.</source> <volume>68</volume>, <fpage>59</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2016.07.007</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camacho</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hegde</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells</article-title>. <source>J. Immunol.</source> <volume>175</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.1.90</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fam</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A review of Agent Orange and its associated oncologic risk of genitourinary cancers</article-title>. <source>Urol. Oncol.</source> <volume>35</volume> (<issue>11</issue>), <fpage>633</fpage>&#x2013;<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1016/j.urolonc.2017.08.029</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Boffetta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Adami</surname>
<given-names>H. O.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer</article-title>. <source>Eur. J. Epidemiol.</source> <volume>29</volume> (<issue>10</issue>), <fpage>667</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-014-9931-2</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>miRDB: An online database for prediction of functional microRNA targets</article-title>. <source>Nucleic Acids Res.</source> <volume>48</volume> (<issue>D1</issue>), <fpage>D127</fpage>&#x2013;<lpage>D131</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz757</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>I. W.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on testicular spermatogenesis-related panels and serum sex hormone levels in rats</article-title>. <source>BJU Int.</source> <volume>101</volume> (<issue>2</issue>), <fpage>250</fpage>&#x2013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1111/j.1464-410X.2007.07202.x</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Gauldie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Szewczuk</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Enhanced suppressor cell activity as a mechanism of immunosuppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>. <source>Proc. Soc. Exp. Biol. Med.</source> <volume>168</volume> (<issue>2</issue>), <fpage>290</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.3181/00379727-168-41275</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Heer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Verlaan</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Penninks</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Vos</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Schuurman</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Van Loveren</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Time course of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced thymic atrophy in the Wistar rat</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>128</volume> (<issue>1</issue>), <fpage>97</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1006/taap.1994.1185</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Rap2B promotes cell proliferation, migration and invasion in prostate cancer</article-title>. <source>Med. Oncol.</source> <volume>33</volume> (<issue>6</issue>), <fpage>58</fpage>. <pub-id pub-id-type="doi">10.1007/s12032-016-0771-7</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma</article-title>. <source>Tumour Biol.</source> <volume>39</volume> (<issue>7</issue>), <fpage>1010428317701653</fpage>. <pub-id pub-id-type="doi">10.1177/1010428317701653</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>12363</fpage>. <pub-id pub-id-type="doi">10.1038/srep12363</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Disner</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Lopes-Ferreira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Where the aryl hydrocarbon receptor meets the microRNAs: literature review of the last 10 years</article-title>. <source>Front. Mol. Biosci.</source> <volume>8</volume>, <fpage>725044</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2021.725044</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dom&#xed;nguez-Acosta</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vega</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Estrada-Mu&#xf1;iz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Elizondo</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Activation of aryl hydrocarbon receptor regulates the LPS/IFN&#x3b3;-induced inflammatory response by inducing ubiquitin-proteosomal and lysosomal degradation of RelA/p65</article-title>. <source>Biochem. Pharmacol.</source> <volume>155</volume>, <fpage>141</fpage>&#x2013;<lpage>149</lpage>. <comment>Epub 2018 Jun 21</comment>. <pub-id pub-id-type="doi">10.1016/j.bcp.2018.06.016</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenberg</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kotaja</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Goldman-Wohl</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Imbar</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>microRNA in human reproduction</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>888</volume>, <fpage>353</fpage>&#x2013;<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-22671-2_18</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Matsumura</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway</article-title>. <source>Biochem. Pharmacol.</source> <volume>52</volume> (<issue>10</issue>), <fpage>1599</fpage>&#x2013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-2952(96)00566-7</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eskenazi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ames</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Signorini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mocarelli</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Dioxin exposure associated with fecundability and infertility in mothers and daughters of Seveso, Italy</article-title>. <source>Italy. Hum. Reprod.</source> <volume>36</volume> (<issue>3</issue>), <fpage>794</fpage>&#x2013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deaa324</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eskenazi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Signorini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ames</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mocarelli</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Seveso accident: A look at 40 years of health research and beyond</article-title>. <source>Environ. Int.</source> <volume>121</volume> (<issue>1</issue>), <fpage>71</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.envint.2018.08.051</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fetissov</surname>
<given-names>S. O.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Mimura</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fujii-Kuriyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rannug</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Expression of hypothalamic neuropeptides after acute TCDD treatment and distribution of Ah receptor repressor</article-title>. <source>Regul. Pept.</source> <volume>119</volume> (<issue>1-2</issue>), <fpage>113</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.regpep.2004.01.009</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fine</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Silverstone</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Gasiewicz</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>. <source>J. Immunol.</source> <volume>144</volume> (<issue>4</issue>), <fpage>1169</fpage>&#x2013;<lpage>1176</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.144.4.1169</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Aryl hydrocarbon receptor-dependent induction of loss of mitochondrial membrane potential in epididydimal spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title>. <source>Toxicol. Lett.</source> <volume>157</volume> (<issue>2</issue>), <fpage>99</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2005.01.008</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frazier</surname>
<given-names>D. E.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Silverstone</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Gasiewicz</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced thymic atrophy and lymphocyte stem cell alterations by mechanisms independent of the estrogen receptor</article-title>. <source>Biochem. Pharmacol.</source> <volume>47</volume> (<issue>11</issue>), <fpage>2039</fpage>&#x2013;<lpage>2048</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(94)90079-5</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaspari</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Paris</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kalfa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Soyer-Gobillard</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Sultan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hamamah</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Experimental evidence of 2,3,7,8-Tetrachlordibenzo-p-Dioxin (TCDD) transgenerational effects on reproductive health</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>16</issue>), <fpage>9091</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22169091</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hites</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Dioxins: an overview and history</article-title>. <source>Environ. Sci. Technol.</source> <volume>45</volume> (<issue>1</issue>), <fpage>16</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1021/es1013664</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huff</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Salmon</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Zeise</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins</article-title>. <source>Cell Biol. Toxicol.</source> <volume>7</volume> (<issue>1</issue>), <fpage>67</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1007/BF00121331</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyyanar</surname>
<given-names>P. P. R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>
<italic>Alx1</italic> deficient mice recapitulate craniofacial phenotype and reveal developmental basis of <italic>ALX1</italic>-related frontonasal dysplasia</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>10</volume>, <fpage>777887</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2022.777887</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Promotion of endometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls</article-title>. <source>Environ. Health Perspect.</source> <volume>105</volume> (<issue>7</issue>), <fpage>750</fpage>&#x2013;<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.97105750</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Camacho</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Role of fas-fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from fas-deficient (lpr) and fas ligand-defective (gld) mice to TCDD-induced toxicity</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>160</volume> (<issue>2</issue>), <fpage>141</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1006/taap.1999.8753</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes <italic>in vivo</italic> and its effect on apoptosis</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>150</volume> (<issue>1</issue>), <fpage>117</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1006/taap.1998.8390</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin <italic>in vivo</italic>
</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>142</volume> (<issue>2</issue>), <fpage>367</fpage>&#x2013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1006/taap.1996.8049</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>S. H.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Immunotoxicological effects of agent Orange exposure to the Vietnam war Korean veterans</article-title>. <source>Ind. Health</source> <volume>41</volume> (<issue>3</issue>), <fpage>158</fpage>&#x2013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.2486/indhealth.41.158</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kociba</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Schwetz</surname>
<given-names>B. A.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title>. <source>Drug Metab. Rev.</source> <volume>13</volume> (<issue>3</issue>), <fpage>387</fpage>&#x2013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.3109/03602538209029986</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohn</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Effects of TCDD on thyroid hormone homeostasis in the rat</article-title>. <source>Drug Chem. Toxicol.</source> <volume>23</volume> (<issue>1</issue>), <fpage>259</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1081/dct-100100114</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Lebedeva</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Suzawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wadekar</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Desclozeaux</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ingraham</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification</article-title>. <source>Mol. Cell Biol.</source> <volume>25</volume> (<issue>5</issue>), <fpage>1879</fpage>&#x2013;<lpage>1890</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.25.5.1879-1890.2005</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sha</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H. Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Effects of perinatal TCDD exposure on colonic microbiota and metabolism in offspring and mother mice</article-title>. <source>Sci. Total Environ.</source> <volume>832</volume>, <fpage>154762</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2022.154762</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Knockdown of Rap2B, a Ras superfamily protein, inhibits proliferation, migration, and invasion in cervical cancer cells via regulating the ERK1/2 signaling pathway</article-title>. <source>Oncol. Res.</source> <volume>26</volume> (<issue>1</issue>), <fpage>123</fpage>&#x2013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.3727/096504017X14912172235777</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maalouf</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Pate</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>MicroRNA in ovarian function</article-title>. <source>Cell Tissue Res.</source> <volume>363</volume> (<issue>1</issue>), <fpage>7</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-015-2307-4</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yaffe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Byers</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Peltz</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Agent Orange exposure and dementia diagnosis in US veterans of the Vietnam era</article-title>. <source>JAMA Neurol.</source> <volume>78</volume> (<issue>4</issue>), <fpage>473</fpage>&#x2013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.5011</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>Q. S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Fabp4-Cre-mediated deletion of the miRNA-processing enzyme Dicer causes mouse embryonic lethality</article-title>. <source>Acta Diabetol.</source> <volume>50</volume> (<issue>5</issue>), <fpage>823</fpage>&#x2013;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1007/s00592-011-0335-4</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma</article-title>. <source>J. Neurooncol</source> <volume>143</volume> (<issue>2</issue>), <fpage>221</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1007/s11060-019-03163-6</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="book">
<collab>National Academies of Sciences</collab> (<year>2018</year>). <source>Engineering, and medicine; health and medicine division; board on population health and public health practice; committee to review the health effects in Vietnam Veterans of exposure to herbicides (eleventh biennial update). Veterans and agent Orange: Update 11</source>. <publisher-loc>Washington (DC)</publisher-loc>: <publisher-name>National Academies Press</publisher-name>.</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neamah</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Alghetaa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Abdulla</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Busbee</surname>
<given-names>P. B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>AhR activation leads to massive mobilization of myeloid-derived suppressor cells with immunosuppressive activity through regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p that target anti-inflammatory genes</article-title>. <source>J. Immunol.</source> <volume>203</volume> (<issue>7</issue>), <fpage>1830</fpage>&#x2013;<lpage>1844</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1900291</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Brien</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hayder</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zayed</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Overview of MicroRNA biogenesis, mechanisms of actions, and circulation</article-title>. <source>Front. Endocrinol. (Lausanne)</source> <volume>9</volume>, <fpage>402</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2018.00402</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patrizi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Siciliani de Cumis</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>TCDD toxicity mediated by epigenetic mechanisms</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume> (<issue>12</issue>), <fpage>4101</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19124101</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Kaffenberger</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Elston</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Skin diseases associated with Agent Orange and other organochlorine exposures</article-title>. <source>J. Am. Acad. Dermatol</source> <volume>74</volume> (<issue>1</issue>), <fpage>143</fpage>&#x2013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2015.05.006</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirkle</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Needham</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Michalek</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Miner</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>1989</year>). <article-title>Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam veterans of operation ranch hand</article-title>. <source>J. Toxicol. Environ. Health</source> <volume>27</volume> (<issue>2</issue>), <fpage>165</fpage>&#x2013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1080/15287398909531288</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Estill</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>L. N.</given-names>
</name>
<name>
<surname>Krawetz</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Scarano</surname>
<given-names>W. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Integrative transcriptome and microRNome analysis identifies dysregulated pathways in human Sertoli cells exposed to TCDD</article-title>. <source>Toxicology</source> <volume>409</volume>, <fpage>112</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2018.08.001</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Smitz</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Epiregulin can effectively mature isolated cumulus-oocyte complexes, but fails as a substitute for the hCG/epidermal growth factor stimulus on cultured follicles</article-title>. <source>Reproduction</source> <volume>137</volume> (<issue>6</issue>), <fpage>997</fpage>&#x2013;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1530/REP-08-0523</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothhammer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Quintana</surname>
<given-names>F. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease</article-title>. <source>Nat. Rev. Immunol.</source> <volume>19</volume> (<issue>3</issue>), <fpage>184</fpage>&#x2013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-019-0125-8</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nynca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ruszkowska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paukszto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Myszczynski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Swigonska</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Transcriptional profiling of Chinese hamster ovary (CHO) cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title>. <source>Reprod. Toxicol.</source> <volume>104</volume>, <fpage>143</fpage>&#x2013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2021.07.012</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scialli</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Ginevan</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Agent Orange exposure and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) in human milk</article-title>. <source>Birth Defects Res. B Dev. Reprod. Toxicol.</source> <volume>104</volume> (<issue>3</issue>), <fpage>129</fpage>&#x2013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1002/bdrb.21145</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>From suppressor T cells to regulatory T cells: how the journey that began with the discovery of the toxic effects of TCDD led to better understanding of the role of AhR in immunoregulation</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>21</issue>), <fpage>7849</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21217849</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression</article-title>. <source>Mol. Pharmacol.</source> <volume>71</volume> (<issue>1</issue>), <fpage>145</fpage>&#x2013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1124/mol.106.028365</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>U. P.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nagarkatti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression</article-title>. <source>PLoS One</source> <volume>7</volume> (<issue>9</issue>), <fpage>e45054</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0045054</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tischkau</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Jaeger</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Krager</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Circadian clock disruption in the mouse ovary in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>. <source>Toxicol. Lett.</source> <volume>201</volume> (<issue>2</issue>), <fpage>116</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2010.12.013</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viluksela</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pohjanvirta</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Multigenerational and transgenerational effects of dioxins</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>12</issue>), <fpage>ijms20122947</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20122947</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdez</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Petroff</surname>
<given-names>B. K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Effect of chronic exposure to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin in female rats on ovarian gene expression</article-title>. <source>Reprod. Toxicol.</source> <volume>28</volume> (<issue>1</issue>), <fpage>32</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2009.03.004</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>V&#xe1;zquez-G&#xf3;mez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Karasov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tylichov&#xe1;</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kab&#xe1;tkov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hampl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Aryl hydrocarbon receptor (AhR) limits the inflammatory responses in human lung adenocarcinoma A549 cells via interference with NF-&#x3ba;B signaling</article-title>. <source>Cells</source> <volume>11</volume> (<issue>4</issue>), <fpage>707</fpage>. <pub-id pub-id-type="doi">10.3390/cells11040707</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergara</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Lizama</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brouwer-Visser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>R. D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Expression of BCL-2 family genes in germ cells undergoing apoptosis during the first wave of spermatogenesis in the rat</article-title>. <source>Andrologia</source> <volume>43</volume> (<issue>4</issue>), <fpage>242</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0272.2010.01058.x</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Role of microRNAs in mammalian spermatogenesis and testicular germ cell tumors</article-title>. <source>Reproduction</source> <volume>149</volume> (<issue>3</issue>), <fpage>R127</fpage>&#x2013;<lpage>R137</lpage>. <pub-id pub-id-type="doi">10.1530/REP-14-0239</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Algers</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hultgren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>I. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pup mortality in laboratory mice--infanticide or not?</article-title> <source>Acta Vet. Scand.</source> <volume>55</volume> (<issue>1</issue>), <fpage>83</fpage>. <pub-id pub-id-type="doi">10.1186/1751-0147-55-83</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>De Castro</surname>
<given-names>K. P.</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Elferink</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Canonical and non-canonical aryl hydrocarbon receptor signaling pathways</article-title>. <source>Curr. Opin. Toxicol.</source> <volume>2</volume>, <fpage>87</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.cotox.2017.01.001</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The roles of microRNAs in epigenetic regulation</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>51</volume>, <fpage>11</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2019.01.024</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Knockdown of Rap2B inhibits the proliferation and invasion in hepatocellular carcinoma cells</article-title>. <source>Oncol. Res.</source> <volume>25</volume> (<issue>1</issue>), <fpage>19</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.3727/096504016X14685034103914</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buekens</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Dioxins and polyvinylchloride in combustion and fires</article-title>. <source>Waste Manag. Res.</source> <volume>33</volume> (<issue>7</issue>), <fpage>630</fpage>&#x2013;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1177/0734242X15590651</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Animal Toxicology studies on the male reproductive effects of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin: data analysis and health effects evaluation</article-title>. <source>Front. Endocrinol. (Lausanne)</source> <volume>12</volume>, <fpage>696106</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2021.696106</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>